Dr. Ryan is on Doximity
As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3303 Sw Bond Ave
7th Floor
Portland, OR 97239Phone(503) 494-6594
- Is this information wrong?
Education & Training
University of ChicagoFellowship, Hematology/Oncology, 1997 - 2000
University of ChicagoResidency, Internal Medicine, 1994 - 1997
State University of New York Upstate Medical UniversityClass of 1994
Certifications & Licensure
OR State Medical License 2003 - 2021
IL State Medical License 1994 - 2005- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Phase 3 Study to Treat Patients With Soft Tissue Sarcomas Start of enrollment: 2014 Jan 01Potvin, A.,McNeill, A.,Italiano, A.,Cubillo, A.,O'Meara, A.,Makepeace, B.,Chmielowski, B.,Malivoir, B.,Alabise, C.,Cagnazzo, C.,Forscher, C.,Dupouy, C.,Moore, C.,Ryan, C.,Verschraegen, C.,Linassier, C.,Bo...
- A Phase II Study of Sorafenib With Chemotherapy, Radiation, and Surgery for High-Risk Soft Tissue Sarcomas Start of enrollment: 2013 Dec 01Ryan, C.W.
- Randomized, Double-Blind Phase III Study of Pazopanib vs. Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease Following Metastatectomy Start of enrollment: 2012 Aug 01Merchant, J.J.,Orcutt, J.M.,Padula, G.,Gartrell, B.A.,Bylow, K.A.,Kuzel, T.,Busiek, D.F.,Reid, T.J.,Song, W.,Alva, A.S.,Marchello, B.T.,Oettel, K.R.,Rose, C.G.,Sleckman, B.G.,Logan, T.F.,Friedman, E.L.,St...
- The Effect of Antiangiogenic Therapy With Pazopanib Prior to Preoperative Chemotherapy for Subjects With Extremity Soft Tissue Sarcomas: A Randomized Study to Evaluate Response by Imaging Start of enrollment: 2012 Apr 01Rodler, E.,Rodler, E.T.
- A Randomized, Double-Blind Phase II, Study of Gemcitabine Alone or in Combination With Pazopanib for Refractory Soft Tissue Sarcoma Start of enrollment: 2012 Mar 01Ryan, C.W.
- S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery Start of enrollment: 2011 Apr 01Christopher W. Ryan, MD
- Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma Start of enrollment: 2009 Feb 01Christopher W. Ryan, MD
Publications & Presentations
PubMed
- Overall survival and histology-specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarco...Patel, S.,von Mehren, M.,Reed, D. R.,Kaiser, P.,Charlson, J.,Ryan, C. W.,Rushing, D.,Livingston, M.,Singh, A.,Seth, R.,Forscher, C.,D'Amato, G.,Chawla, S. P.,McCarthy,...> ;Cancer. 2019 Jun 08
- Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma.Davis, L. E.,Bolejack, V.,Ryan, C. W.,Ganjoo, K. N.,Loggers, E. T.,Chawla, S.,Agulnik, M.,Livingston, M. B.,Reed, D.,Keedy, V.,Rushing, D.,Okuno, S.,Reinke, D. K.,Ried...> ;J. Clin. Oncol.. 2019 Apr 24
- ASO Author Reflections: Chemoradiation for High-Risk Soft Tissue Sarcomas.Eric Lu, Christopher W. Ryan> ;Annals of Surgical Oncology. 2018 Oct 26
- Join now to see all
Press Mentions
Analysis of Human Performance Deficiencies Associated with Surgical Adverse EventsAugust 15, 2019 00:25
SWOG Launches National Immunotherapy Clinical Trial for Rare CancersJanuary 19, 2017 11:20
Professional Memberships
- Member
Hospital Affiliations
OHSU HospitalPortland, Oregon
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
